Complement, Alternate Pathway (AH50), Functional, Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Investigation of suspected alternative pathway complement deficiency, atypical hemolytic uremic syndrome, C3 glomerulonephritis, dense-deposit disease
Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Complement, Alternate Path, Func, S